INTRODUCTION
Mammalian prion diseases are fatal neurodegenerative conditions of humans and various other vertebrate species. These diseases include scrapie in sheep, BSE (bovine spongiform encephalopathy) in cattle and CJD (Creutzfeldt-Jakob disease) in humans. Collectively, these diseases may be inherited, arise sporadically or occur through environmental exposure to infectious prion material [1] . All of these prion disease manifestations appear to share the same pathogenic mechanism, which involves the misfolding and aggregation of the normal host protein PrP c [normal cellular PrP (prion protein)] into a polymeric β-sheet-rich isoform termed PrP Sc (abnormal diseasespecific conformation of PrP) [2] . During the course of prion diseases, prion infectivity and PrP Sc accumulate in the brains of prion-infected individuals.
Prion diseases are a significant threat to public health through their potential for zoonotic transmission, as evidenced by the BSE epidemic in U.K. cattle and subsequent emergence of variant CJD in humans [3] . As a consequence, much attention has focused on the molecular basis of prion propagation and the transmission barrier that controls passage of prions between species. Central to these studies has been the analysis of scrapie of sheep, the prototypic prion disease. In the sheep PrP, four major polymorphisms located at amino acid residues 136, 141, 154 and 171 are associated with susceptibility to different types of scrapie disease [4, 5] . All four major polymorphic amino acid residues are located within, or close to, regions that are believed to undergo major conformational change during the conversion of PrP c to PrP Sc [6] . Sheep [5] . Atypical scrapie disease typically occurs in old sheep and is not thought to be naturally transmissible [8] .
A fundamental feature of the conversion of PrP c into PrP Sc during the pathogenesis of prion diseases involves an increase in β-sheet structure in the PrP [9] . We have previously demonstrated that the susceptibility to different types of scrapie correlates with the ease of unfolding of the C-terminus of α-helix-2 in ovine PrP and the formation of an extended β-sheet structure in the central portion of the molecule [10] . These conformational events in ovine PrP were influenced by amino acid residue 154 located in α-helix-1. This suggests that the different genotypes of ovine PrP protein associated with either classical or atypical scrapie have different propensities to misfold into a neurotoxic form. In addition, our own data and results by others have shown that PrP associated with susceptibility to classical scrapie is more compact than that associated with atypical scrapie [11] [12] [13] . This has led to a view that differences in the metabolism of allelic variants of ovine PrP contribute to the mechanism(s) that determine susceptibility and resistance of sheep to scrapie disease [13, 14] .
Owing to the protracted nature of scrapie disease in sheep, new animal models of this condition are required in order to allow detailed studies on the specific contribution of different ovine PrP polymorphisms to ovine PrP misfolding and formation of a neurotoxic transmissible molecule. Specifically, a genetically well-defined animal model is required in order to analyse the genes and metabolic pathways that may affect ovine PrP misfolding and aggregation of different genotypes of ovine PrP. The successful application of ovine PrP transgenesis in rendering xenogeneic hosts susceptible to ovine prions [15, 16] provides an opportunity to explore the development of nonmammalian animal models of sheep scrapie, and prion diseases in general, in pursuit of a more tractable genetic model of these conditions. Drosophila melanogaster has emerged as a model system for the study of complex biological processes, such as mammalian neurodegenerative disease [17] . This has arisen because Drosophila and mammals show conservation of fundamental elements of the nervous system and biochemical pathways [18] . Drosophila is a genetically well-defined organism that lends itself to the production of transgenic flies that express proteins in a tissue-specific distribution. The normal physiology and development of Drosophila is well characterized so that behavioural assays can readily detect neurotoxicity in the live organism [19] . Large numbers of flies can be produced in a short time, which correlates with their relatively short lifespan [20] , allowing rapid statistically robust data collection. Significantly, Drosophila have been used to model a number of human neurodegenerative diseases including Alzheimer's disease [21] [22] [23] , Parkinson's disease [24, 25] , tauopathies [26, 27] and GSS (Gerstmann-Sträussler-Scheinker) syndrome [28, 29] . Drosophila melanogaster is therefore a suitable animal model for in vivo analysis of ovine PrP in an attempt to produce an invertebrate model of sheep scrapie disease.
In the present study we have generated for the first time Drosophila transgenic for ovine PrP in order to begin to establish an invertebrate model of ovine prion disease. We have used PhiC31-mediated site-specific germ-line transformation [30] to generate Drosophila transgenic for polymorphic variants of ovine PrP that express under the control of the bi-partite GAL4/UAS (upstream activating sequence) system. Site-specific transgene insertion in the fly genome has allowed us to test the hypothesis that single amino acid codon changes in ovine PrP affect PrP expression in Drosophila. This is an important question to address, since potential spontaneous detrimental effects of heterologous ovine PrP expression in Drosophila need to be established before investigation of exogenous ovine prion infection in these novel fly lines. The present study shows that high levels of ovine PrP expression are associated with phenotypic effects, including decreased locomotor activity and decreased survival. Significantly, the present study highlights a critical role for helix-1 in the formation of distinct conformers of ovine PrP, since expression of His 154 variants were associated with decreased survival in the absence of high levels of ovine PrP expression. Collectively, the present study provides an important contribution to the development of an invertebrate model of mammalian prion disease.
EXPERIMENTAL

Generation of ovine PrP transgenic Drosophila
The ovine PrP transgene for insertion into the Drosophila genome was prepared by a two-step PCR. A DNA fragment of 697 bp which encoded ovine PrP amino acids 25-232 was generated by PCR using plasmid DNA as a substrate that contained a specific genotype of ovine PrP and oligonucleotide primers PD1F (5 -GTCCATCTTCTGGCTGCTCAGACCTTCGCCCAGAAGAA-GCGACCAAAACCTGG-3 ) and PD1R (5 -GGAGGATCACA-GGAGGGGAAGAAAAGAGGATCACACTTGCCCCCCTTT-GGTAATCTGGG-3 ) in the presence of Pfu DNA polymerase (Promega). The PCR conditions consisted of an initial denaturation at 95
• C for 2 min followed by 30 cycles of denaturation at 95
• C for 30 s, primer annealing at 55
• C for 30 s and extension at 72
• C for 1 min, and a final extension of PCR products at 72
• C for 10 min. A second PCR was carried out using the product of the first PCR as the substrate and oligonucleotide primers PD2F (5 -GGCGAATTCATGGCGAGCAAAGTC-TCGATCCTTCTCCTGCTAACCGTCCATCTTCTGC-3 ) and PD2R (5 -GTCCGCTCGAGCTATCCTACTATGAGAAAAAT-GAGGAAAGAGATGAGGAGGATCGAGGGG-3 ). The 788 bp product of the second PCR comprised DNA encoding an insect secretion signal peptide at the 5 end [31] followed by DNA encoding ovine PrP amino acid residues 25-232, and the DNA encoding the ovine PrP GPI (glycosylphosphatidylinositol) anchor signal sequence (amino acid residues 233-256) at the 3 end. The reaction conditions for this second PCR were the same as for the first apart from the primer annealing temperature, which was 64
• C for 30 s. The PCR primers PD2F and PD2R contained EcoRI and XhoI restriction sites respectively that allowed directional cloning of the 788 bp PCR product into the Drosophila transgenesis vector pUASTattB. Primer PD2R contained a stop codon ahead of the XhoI restriction site. Four different transgene constructs were generated that contained DNA encoding ARQ, AHQ, VRQ or VHQ ovine PrP, and each construct was subsequently ligated into pUASTattB and rescued by transformation in DH5α bacteria. Plasmid DNA was isolated from transformed bacteria by an alkaline lysis method using the Qiagen maxiprep kit and the PrP construct insert was verified by DNA sequence analysis. Site-specific transformation of the pUASTattB-PrP constructs into the 51D fly line (y [1] M{vas-int.Dm}ZH-2A w[*]; M{3xP3-RFP.attP}ZH-51D) was performed by Bestgene. F1 flies were balanced and viable lines were maintained as balanced stocks by conventional fly crosses. DNA sequence analysis was performed on genomic DNA from each balanced fly line to confirm the presence of the correct PrP genotype. This procedure generated UAS-PrP fly lines that were transgenic for ARQ, AHQ, VRQ or VHQ ovine PrP. The VHQ PrP construct acquired a C→A point mutation during transgenesis in Drosophila that resulted in a Asp→Glu dimorphism at codon 147 of the ovine PrP.
Fly stocks
Actin-5C-GAL4 (y w; P{w[
) and GMR-GAL4 (w; wg[Sp-1]/CyO; GMR-Gal4, w + /TM6B) driver lines and the control 51D (w; M{3xP3-RFP.attP}ZH-51D) fly line were obtained from the Department of Genetics, University of Cambridge, Cambridge, U.K. All fly lines were raised on standard cornmeal medium [32] at 25
• C, maintained at low-to-medium density and all experiments were performed with pre-mated females. Flies were harvested at various time points and either frozen at − 80
• C until required, or whole brains were isolated immediately for immunostaining and confocal microscopy.
Preparation of fly head homogenates
Female fly heads were removed by decapitation induced by immersion of tubes containing whole flies in liquid nitrogen for 10 min followed by 2 min of vortex-mixing. Homogenates were prepared by manual grinding of fly heads in eppendorf tubes with sterilized plastic pestles. Homogenates for (i) RT (reverse transcription)-PCR were prepared by processing 15 fly heads in 100 μl of TRIzol ® reagent (Invitrogen) followed by centrifugation of the mixture at 12 000 g for 10 min at 4
• C and retention of the supernatant; and (ii) immunodetection of PrP were prepared by processing 20 fly heads in 20 μl of lysis buffer [50 mM Tris/HCl (pH 7.5), 100 mM NaCl, 0.5 % Nonidet P-40 and 1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride] followed by 10 min of sonication on ice.
Quantitative RT-PCR
Fly head homogenate prepared from 3-day-old flies was transferred to a fresh RNase-free eppendorf tube that contained 50 μl of TRIzol ® reagent, thoroughly mixed and incubated for 5 min at 21
• C. Chloroform (30 μl) was added to each tube and the samples were mixed vigorously for 15 s before centrifugation at 12 000 g for 15 min at 4
• C. The aqueous phase was transferred to a clean tube that contained 75 μl of propan-2-ol, mixed vigorously for 15 s and centrifuged at 12 000 g for 10 min at 4
• C. The pellet was washed in 75 % ice-cold ethanol [diluted in DEPC (diethylpyrocarbonate)-treated water]. The sample was then centrifuged at 10 000 g for 10 min at 4
• C. The supernatant was discarded and the pellet was air-dried and dissolved in 20 μl of DEPC-treated water. The concentration of total RNA purified for each sample was measured using a NanoDrop spectrophotometer. Target RNA (500 ng) was used for each RT reaction to generate cDNA using the Promega Two-Step Reverse Transcription System (Promega) with random primers. Quantitative RT-PCR was performed using the fluorescent DNA-binding dye BRYT TM Green (Promega). Each sample was analysed in duplicate, with the target gene and control gene in parallel. PrP primers used were forward, 5 -GTGGCTACATGCTGGGAAG-3 , and reverse, 5 -TGGTTGGGGTAACGGTACAT-3 ; and β-actin primers used were forward, 5 -GTGCTATGTTGCCCTCGACT-3 , and reverse, 5 -GTAGGTGGTCTCGTGGATGC-3 . The PrP transcript level was normalized against the β-actin transcript level in the respective samples.
Preparation of total, soluble and insoluble PrP fractions
Various PrP fractions were prepared from fly head homogenates using a method adapted from Fernandez-Funez et al. [33] . In duplicate, a volume of fly head homogenate that was equivalent to 20 fly heads was mixed with 20 μl of 10% (w/v) Sarkosyl (pH 7.4). The sample was shaken at 225 rev./min for 10 min at 37
• C, 5 units of Benzonase ® was added and the sample was shaken at 225 rev./min for a further 10 min at 37
• C. Sodium phosphotungstic acid [diluted in PBS (pH 7.4)] was added to the reaction mix to give a 0.3 % final concentration, and the tubes were shaken at 225 rev./min for 30 min at 37
• C before centrifugation at 16 000 g for 30 min at 4
• C. To obtain the total PrP fraction the pellet was resuspended in the fluid already present in the tube (40 μl) . To obtain the soluble and insoluble PrP fractions, the supernatant (soluble fraction, 40 μl) was transferred to a fresh tube and the pellet (insoluble fraction) was resuspended in 40 μl of 0.1% Sarkosyl in PBS (pH 7.4).
SDS/PAGE and Western blot analysis
Unfractionated or fractionated fly head homogenate was mixed with an equal volume of 2× Laemmli loading buffer, boiled for 10 min, cooled on ice and then centrifuged at 13 000 g for 5 min at 18
• C to remove debris. A volume of sample, typically equivalent to ten fly heads per track, was subjected to SDS/PAGE run under reducing conditions and Western blot analysis as described in detail previously [34] , except that the nitrocellulose membranes were probed with a 1:2000 dilution of the anti-PrP monoclonal antibody Sha31 [35] .
Capture-detector immunoassay
Duplicate 40 μl aliquots of total, soluble and insoluble fly head homogenate were diluted to 100 μl with PBS (pH 7.4). PrP was quantified by capture-detector immunoassay carried out as described previously [36] , except that the capture monoclonal antibody was 245 [37] and the detector antibody was biotinylated SAF32 [35] .
Immunohistochemistry
Immunostaining of isolated adult fly brains was performed as described previously [38] with minor modification. Isolated fly brains were fixed in 2 % formaldehyde for 1 h and then blocked overnight at 4
• C before a further overnight incubation with 50 μg/ml of the monoclonal antibody 6H4 [39] . Fly brains were subsequently incubated overnight at 4
• C with Alexa Fluor ® 488-labelled goat anti-mouse IgG diluted 1:2000.
Confocal microscopy and image processing
Image stacks were acquired with a Leica SP5 confocal microscope using a ×20 glycerol-immersion objective at 1 μm z-spacing. Image stacks were analysed and rendered as maximum intensity projections using Amira5.4 (Visage Imaging).
Locomotor assay
The locomotor ability of flies was assessed in a negative geotaxis climbing assay as described previously [38] . Briefly, age-matched female flies (triplicate samples, n = 15 for each genotype) were anaesthetized with CO 2 and placed in adapted plastic 25 ml pipettes that were used as vertical climbing columns. The flies were allowed to recover for 30 min before assessment of their locomotor ability. Flies were tapped to the bottom of the pipette (using the same number and intensity of taps) and then allowed to climb for 45 s. At the end of the climbing period the number of flies above the 25 ml mark, the number below the 2 ml mark, and the number between the 2 ml and 25 ml mark were recorded. This procedure was performed three times at each time point. The mean + − S.D. performance index for each group of flies was calculated as described in [38] .
Survival assay
Newly eclosed flies were allowed to mature and mate for 24 h before the females were separated and collected for survival assays. Then 100 flies of each genotype were housed in groups of ten, and the flies were flipped every 2-3 days on to fresh food. The number of dead flies was recorded three times a week [23] . Survival curves were calculated using Kaplan-Meier plots and the differences between them were analysed by the log-rank method using GraphPad Prism.
Statistical analysis
Statistical analysis of the data was performed by one-way ANOVA, together with Tukey HSD (highly significant difference) for post-hoc analysis or the paired samples t test using GraphPad Prism.
RESULTS
Generation of ovine PrP transgenic Drosophila
Susceptibility to different types of scrapie disease in sheep are associated with dimorphisms in ovine PrP. The location of the major amino acid codons that determine this variation in sheep scrapie disease susceptibility are shown in Figure 1 . In the present study we have generated Drosophila transgenic for different polymorphic variants of ovine PrP through the use of the site-specific PhiC31 integrase system [30] . The ovine PrP variants investigated were ARQ, AHQ, VRQ and VHQ. These PrP variants, which contain A136V or R154H amino acid substitutions, are all reported to occur naturally in sheep [40, 41] . The PrP transgene used in the present study comprised DNA encoding mature length ovine PrP (amino acid residues 25-231) flanked by the coding sequence of an insect leader sequence peptide [31] at the 5 end and the coding sequence of the ovine GPI anchor sequence at the 3 end. The PrP construct was ligated into the Drosophila integration vector pUASTattB and injected into embryos. Stable balanced UAS-ovine PrP transgenic fly lines were generated by conventional fly crossing. Analysis by PCR confirmed that each of the ovine PrP transgenes was located at the 51D-specific attP landing site in the appropriate fly line (results not shown). UAS-ovine PrP transgenic fly lines were eventually crossed with Actin-5C-GAL4 (β-actin-GAL4), GMR-GAL4 or Elav-GAL4 driver fly lines to allow ubiquitous expression of ovine PrP in the photoreceptors and peripheral nervous cells of the eye, or pan-neuronally respectively.
Genotypic variation of ovine PrP expression in Drosophila
The mRNA level for each of the ovine PrP variants expressed in Drosophila was assessed by quantitative RT-PCR. As a control, we measured the mRNA levels of the endogenous gene β-actin to allow a relative comparison of PrP mRNA levels between the different fly lines. The results in Figure 2 show that ubiquitous and pan-neuronal expression of the ovine PrP transgenes under the control of β-actin-GAL4 and Elav-GAL4 respectively, resulted in significantly higher levels of ARQ PrP mRNA compared with all other genotypes of ovine PrP expressed in Drosophila. A similar trend was seen following expression of the ovine PrP transgenes in the fly eye under the control of GMR-GAL4. The level of AHQ, VRQ and VHQ PrP mRNA was reasonably similar following expression under the control of β-actin-GAL4, GMR-GAL4 and Elav-GAL4.
We next investigated the expression of ovine PrP in Drosophila under the control of different tissue-specific promoters. The Western blot analysis in Figure 3 shows that ovine PrP expressed in Drosophila had a molecular mass of 29-31 kDa and comprised at least two major protein bands, and a third less intense band, similar to that of other species forms of PrP expressed in Drosophila [28, 29, 33, 42, 43] . The lower molecular mass observed for ovine PrP expressed in Drosophila most probably arises because N-linked glycosylation differs in insects from that in mammals [44] . In Drosophila post-synthetic trimming reactions of N-linked glycosylation moieties result in a lack of sialylation in contrast with the complex sugar groups that are added to proteins in mammalian systems. The molecular mass of ovine PrP expressed in Drosophila was similar when detected by N-or Cterminal-specific anti-PrP monoclonal antibodies, indicating that the protein was predominantly full-length (results not shown).
During prion diseases, PrP undergoes a conformational change from a predominantly α-helical form that is soluble in nonionic detergents into one enriched for β-sheet structure that is aggregated and insoluble in detergent [45] . Accordingly, we investigated whether these different conformers of the PrP were present in ovine PrP transgenic Drosophila. To do this, detergentsoluble and -insoluble fractions of PrP were prepared from fly head homogenates and analysed first by Western blotting. The results in Figure 4 show that although the majority of ovine PrP expressed pan-neuronally in Drosophila was soluble, a significant proportion was present as insoluble material that was susceptible to Sarkosyl extraction and sodium phosphotungstic acid precipitation.
Although the same molecular profile was evident for all of the variants of ovine PrP expressed in Drosophila, genotypic tissue-specific differences in expression levels and the relative proportions of soluble and insoluble PrP were evident. We quantified these differences by a sensitive capture-detector immunoassay using C-terminal-specific anti-PrP monoclonal antibodies. Figure 5 shows that, following ubiquitous expression (Figure 5a ) and pan-neuronal expression (Figure 5c ) the highest level of PrP expression was seen in ARQ PrP transgenic flies, which was ≈1.5-and ≈2-fold higher respectively than the level seen in all other ovine PrP transgenic flies. The amount of ARQ PrP expressed pan neuronally in a single fly head was estimated to be ≈0.6 ng. In contrast with the levels of ovine PrP expressed ubiquitously and pan neuronally, similar levels of ARQ and VRQ PrP were detected following expression in the fly eye (Figure 5b ), which were both ≈1.5-fold higher than that seen for AHQ and VHQ PrP protein levels in the same tissue. Although the majority of ovine PrP expressed in ovine PrP transgenic Drosophila comprised soluble material, each genotype of ovine PrP displayed a significant fraction of insoluble material. However, the level of insoluble PrP was dependent upon the cell type(s) in which the protein was expressed. For example, a relatively low level of insoluble PrP was seen for all ovine PrP genotypes following panneuronal expression (Figure 5c ), but relatively high levels were seen upon expression in the fly eye (Figure 5b) . Furthermore, following expression in the fly eye, the levels of insoluble AHQ and VHQ ovine PrP were lower than those of ARQ and VRQ ovine PrP (Figure 5b ).
Distribution of ovine PrP expression in the CNS (central nervous system) of Drosophila
In order to investigate the distribution of ovine PrP in the fly CNS following pan-neuronal expression, we performed confocal microscopic analysis on the brains isolated from ovine PrP transgenic Drosophila. Figure 6 shows a projection analysis throughout whole adult Drosophila brains stained with the antiPrP monoclonal antibody 6H4. Ovine PrP expression was clearly evident in major neuropil areas within the central brain region of adult ovine PrP transgenic Drosophila. All of the different genotypes of ovine PrP transgenic flies showed a punctate distribution of PrP, with an apparent relative enrichment in neuropil areas, including the antennal lobes, the sub-oesophageal ganglion and the mushroom bodies. PrP expression was also evident in neuronal cell bodies of PrP transgenic fly lines, although the level of expression showed genotypic variation of the order ARQ>VRQ>VHQ = AHQ. Figure 6 also shows that monoclonal antibody 6H4 has no reactivity with control Elav>51D fly brains.
PrP transgenic Drosophila show reduced locomotor activity
It was apparent from routine observation of the ovine PrP transgenic Drosophila that there were differences in their locomotor activity. In order to quantify this phenotypic difference between the different fly lines we measured their locomotor activity in a negative geotaxis climbing assay. Flies at various times after hatching were placed in a graduated pipette and allowed to acclimatize for 30 min. The data in Figure 7 show the climbing ability of the ovine PrP transgenic Drosophila during their aging process, expressed as a performance index. At the time of hatching, all of the ovine PrP transgenic fly lines showed a performance index similar to that of control 51D flies, except ARQ PrP Drosophila, which showed an approximately 30 % reduction in climbing ability compared with control flies. As the flies aged, all of the fly lines, except ARQ PrP Drosophila, showed a similar gradual decrease in locomotor activity that was reduced by ≈25 % at 30 days of age. In contrast, ARQ ovine PrP transgenic flies showed a less marked decrease in their climbing assay performance index to that seen by all of the other fly lines. The locomotor activity of the ARQ ovine PrP transgenic flies was statistically significant in comparison with all other fly genotypes over the time points measured (P < 0.001).
Reduced median survival in ovine PrP transgenic Drosophila
The median survival times of the various ovine PrP transgenic fly lines was measured in order to assess whether pan-neuronal PrP expression had any effect upon the lifespan of Drosophila. Flies were housed in groups of ten, transferred to fresh food every 2-3 days and the number of dead flies was counted and recorded on a regular basis. Figure 8 shows the survival curve for each of the ovine PrP transgenic fly lines that pan-neuronally expressed PrP in comparison with the control Elav>51D fly line. All of the fly lines showed similar survival rates up to approximately 35 days of age, after which time differences in mortality rates became apparent. Log-rank test analysis showed that ARQ, AHQ and VHQ PrP transgenic Drosophila survival curves were all significantly different from that of the control 51D fly line (P 0.0002). In contrast, the median survival time of VRQ ovine PrP transgenic flies was not significantly different from the control 51D flies. The median survival times (days + − S.D., n = 2 experiments) of the different fly lines was: (i) 51D, 74 + − 1.4; (ii) ARQ, 55 + − 2.1; (iii) AHQ, 59 + − 0.7; (iv) VRQ, 72 + − 2.8; and (v) VHQ, 61 + − 0.7.
Quantification of PrP accumulation in aged ovine PrP transgenic Drosophila
The decreased median survival time seen by some ovine PrP transgenic fly lines following pan-neuronal expression of the PrP may have been a consequence of the accumulation of distinct conformers of the protein as the animals age. In order to test this Groups of 100 age-matched Elav>PrP (ARQ, ; AHQ, ᮀ; VRQ, ᭺; and VHQ, ) or control Elav>51D flies (᭹) were selected for survival assays. The number of surviving flies was recorded three times a week as described in the Experimental section, and survival curves were calculated using Kaplan-Meier plots and differences between them were analysed using the log-rank method.
we first used Western blot analysis to assess the level of total PrP that accumulated in the different fly lines with time after hatching. Between the time of eclosure and 45 days of age the level of total PrP in each of the different ovine PrP transgenic fly lines remained reasonably constant with no change in molecular profile (results not shown). We next quantified the level of total, soluble and insoluble PrP in ovine PrP transgenic flies at different ages in order to determine whether changes in the distribution of PrP conformers, and therefore potentially pathological forms of the PrP, accumulated in older flies. The data in Figure 9 show that the level of total, soluble and insoluble PrP remained reasonably constant between the time of eclosure and 45 days of age for all of the different ovine PrP transgenic fly lines. These data suggest that the decrease in survival of ovine PrP transgenic Drosophila is not merely a consequence of the level of ovine PrP expression or the level of insoluble and potentially aggregated PrP.
DISCUSSION
Prion diseases affect both human and animal health. It is important to understand the molecular pathogenesis of these fatal transmissible neurodegenerative diseases because of their potential for zoonosis. This is highlighted by the emergence of vCJD (variant CJD) in humans as a consequence of the BSE epizootic in cattle. Prion diseases are difficult to study in the natural hosts because ruminants and humans are outbred populations, which renders genetic analysis difficult and the natural forms of these diseases take many years to develop. New tractable animal models of prion diseases are required in order to identify the biochemical pathways of prion formation and clearance from infected hosts, and the genetic modifiers that regulate these processes. This will allow the identification of new diagnostic markers for prion diseases and potential therapeutic targets. In pursuit of these goals we have generated Drosophila that express polymorphic variants of the ovine PrP. PrP expressed in its natural mammalian host has a molecular mass of 30-35 kDa and comprises unglycosylated and N-linked mono-and di-glycosylated variants [46, 47] . The ovine PrP expressed in Drosophila displayed a molecular mass of approximately 29-31 kDa and comprised two major protein bands and a third minor component. The similar molecular profile of ovine PrP expressed in its natural host and Drosophila suggest that this protein is authentically processed in the fly and in a manner compatible with that seen for other species forms of PrP expressed in the fly [28, 29, 33, 42, 43] . The lower molecular mass for mammalian PrP expressed in Drosophila compared with that seen in its natural host is likely to represent the differences in protein glycosylation between the invertebrate and mammalian species [44] . Although the expression of the PrP is essential for prion diseases to occur, glycosylation of PrP is not essential for the establishment of prion disease within a host. Mice that express only unglycosylated PrP can sustain prion disease, although different prion strains appear to have different requirements for each of the glycosylation sites of host PrP [48] . We found that all of the ovine PrP polymorphic variants expressed in Drosophila showed the same molecular profile, although genotypic variation in protein expression level was seen that was cell-type-specific. All of the ovine PrP transgenic flies were characterized by punctate PrP distribution within neuropil areas of the central brain region, including the antennal lobes, sub-oesophageal ganglia and mushroom bodies. PrP expression was also evident in neuronal cell bodies, in particular in those flies that expressed the ARQ or VRQ genotypes of ovine PrP.
The highest level of ovine PrP expression was seen in ARQ PrP transgenic flies and was 2-fold higher than all other ovine PrP variants when expressed pan-neuronally. This relatively high level of ARQ PrP expression correlated with elevated levels of ARQ PrP mRNA compared with that seen for other genotypes of ovine PrP flies. However, this was not the case in the fly eye where similar PrP levels were seen for all of the different ovine PrP genotypes, despite this tissue displaying high levels of ARQ mRNA in comparison with other PrP transcript levels. These differences in ovine PrP transcript and protein level may reflect tissue-specific variation in PrP mRNA stability, transcriptional and/or translational control, or alternatively a difference in metabolism of ovine PrP variants expressed in Drosophila. Variation in tissue expression of PrP in Drosophila has been reported for the mutant human PrP molecule PG14 which is associated with an inherited form of CJD [28] .
PG14 protein expression was suppressed in Drosophila neurons, reportedly by a post-transcriptional regulatory mechanism that maintained the protein in a detergent-soluble conformation. In the present study we found that the level of insoluble ovine PrP in Drosophila neurons was less than that observed following PrP expression in the fly eye. These observations suggest that Drosophila neurons operate a mechanism that appears to prevent the accumulation of those PrP variants that have a propensity to misfold, or that are potentially detrimental to the cell. In this context it is worth noting that VRQ ovine PrP is associated with a high susceptibility for classical scrapie, which appears to correlate with its potential to convert into a β-sheet-enriched structure [13, 14] . Accordingly, the lower level of PrP neuronal expression in Drosophila by some genotypes of ovine PrP would appear to correlate with their potential to adversely affect the fly.
Neuronal expression of ovine PrP in Drosophila had significant phenotypic effects on the fly and this was dependent upon the genotype and level of PrP expressed. The high level of ARQ PrP expression was associated with a decreased locomotor activity in adult ovine PrP transgenic flies. This locomotory phenotype in ARQ flies, which was evident at the time of eclosure, showed a gradual increase in severity as the transgenic Drosophila aged. The high level of neuronal ovine PrP expression in ARQ PrP transgenic flies also affected longevity as these flies displayed a median lifespan that was significantly reduced compared with that of control non-transgenic 51D flies. These results suggest that overexpression of ovine PrP in Drosophila can be associated with a general adverse effect that manifests as decreased locomotor activity of flies and decreased overall survival. However, this would not appear to be entirely the case since AHQ and VHQ flies, which both express His 154 , showed a significant reduction in median survival time compared with control non-transgenic Drosophila, but expressed significantly less PrP than ARQ PrP flies. Furthermore, Drosophila expressing His 154 variants showed a similar level of PrP expression to VRQ PrP transgenic flies, which did not show any difference in longevity compared with control non-transgenic 51D flies. These observations show that, in the case of VRQ and VHQ, a single amino acid change, namely an R154H polymorphism, results in significant change in pathogenic potential induced by the ovine PrP in Drosophila. The mechanism of the detrimental effect induced by His 154 PrP variants is likely to be different to that caused by the relatively high level of ARQ PrP expression, since the former did not show any defect in locomotor activity. The His 154 variants AHQ and VHQ showed a lower level of insoluble PrP when expressed in the fly eye compared with the Arg 154 variants ARQ and VRQ. This reinforces the view that polymorphisms at amino acid residue 154 within helix-1 of ovine PrP play an important role in regulating the unfolding of this protein and aggregation of this protein [10] . PrP α-helix-1 is extremely hydrophilic, with a high propensity to adopt a helical structure, and has been implicated in the misfolding of PrP [49] [50] [51] , although its role is unclear. It has been suggested that helix-1 unwinds during the conversion of PrP c into PrP Sc to provide more β-sheet structure [50, 52] or may be involved in intermolecular salt bridges during aggregation of PrP Sc [49] . At least one of the His 154 variants examined in the present study, namely the AHQ genotype of ovine PrP, is associated with susceptibility to atypical scrapie, an ovine prion disease distinct from classical scrapie, which is associated with ARQ and VRQ PrP genotypes. The low frequency of the VHQ variant in sheep flocks prevents a detailed study of its association with particular types of scrapie [41] . However, disease-associated PrP that accumulates in cases of atypical scrapie is less resistant to proteolysis than its counterpart in classical scrapie. Significantly, the molecular profile of PrP Sc from atypical scrapie resembles that seen in GSS syndrome, a genetic form of human prion disease. The relatively high occurrence of atypical sheep scrapie in flocks with increased frequency of the AHQ ovine PrP allele, coupled with the view that this condition is considered not to be naturally transmissible between sheep, has led to the opinion by some that atypical scrapie could be a genetic or spontaneous form of ovine prion disease [8] . Our expression of His 154 variants of ovine PrP in Drosophila provides a novel model system to investigate their neurotoxic potential.
During spontaneous and acquired mammalian prion diseases, PrP c undergoes a conformational change to the disease-associated form PrP Sc , which accumulates in affected individuals [53, 54] . This conformational change in PrP is associated with alterations in its biochemical and physico-chemical properties that can result in PrP aggregation, detergent insolubility and resistance to proteolytic digestion. Different conformations of the PrP were evident in ovine PrP transgenic Drosophila, as demonstrated by the presence of detergent-soluble and -insoluble PrP. The detergent-insoluble fraction did not appear to contain proteolyticresistant material since PrP present in different tissues of the fly, which was characterized by distinct levels of detergent-insoluble PrP, showed a similar sensitivity to proteinase K digestion (results not shown). Furthermore, the proportion of detergent-insoluble PrP present within neurons of ovine PrP transgenic Drosophila did not change significantly as the flies aged, which suggested that this PrP fraction was not responsible for the detrimental effects of the protein seen here. However, we cannot exclude the possibility that the insoluble fraction of PrP has exerted a detrimental effect during Drosophila development that manifests upon the phenotype of the fly during adulthood. In addition, the potentially neurotoxic form of ovine PrP expressed in Drosophila may represent a minor component of the bulk population of molecules we have assessed by our immunobiochemical assays. In other studies, where different species forms of PrP have been expressed in Drosophila, including wild-type mouse and hamster PrP, a decrease in locomotor activity was reported to correlate with an increase in the insoluble fraction of PrP as flies aged [33] . The difference in the findings of the studies reported in the present study and those of others [33] may have arisen because of the different species forms of PrP investigated or the different strategies used to mediate PrP transgenesis and expression.
Collectively, the present study shows that different genotypes of ovine PrP can be successfully expressed in Drosophila, and that genotypic variation in ovine PrP expression occurs in this invertebrate host. Significantly, the expression of different variants of the ovine PrP was associated with different phenotypes of the fly. The different effects we have observed are not considered to be due to a positional mutational effect, since our PrP transgenic flies have been generated by PhiC31-mediated germ-line transformation that has used a single landing site in the fly genome. In this context our data provide an accurate comparison of the effects of different genotypes of PrP expression in Drosophila. Our ability to distinguish ovine PrP phenotypic effects in Drosophila allows us to progress to investigate the effect of exogenous ovine prions in this novel invertebrate ovine PrP transgenesis model.
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